NCT06868615

AVAVA MIRIA General Use

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: AVAVA, Inc. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

A general protocol to treat a variety of dermatologic conditions and collect patient feedback. Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.

Conditions

• Acne
• Acne Scars - Mixed Atrophic and Hypertrophic
• Scars
• Wrinkle
• Pigment; Lesion
• Skin Texture Disorder

Interventions

Type	Name	Description
DEVICE	AVAVA	1550nm Non-Ablative Fractional Laser

Timeline

• Start date: 2024-09-11
• Primary completion: 2027-12-30
• Completion: 2027-12-30
• First posted: 2025-03-11
• Last updated: 2025-03-11

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study